Kalaris Therapeutics, Inc. (KLRS): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$165.0K
Year ended 2019-12-31
Period endedRevenueChange YoYSource filing
2019-12-31$165.0Kn/a2021-02-12, From 2019-01-01